These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 38777038
1. Renalism with Renin Angiotensin Aldosterone System Blockade: What Is the Consensus in Advanced Chronic Kidney Disease? Turino Miranda K, Ahmed SB. Can J Cardiol; 2024 Sep; 40(9):1729-1731. PubMed ID: 38777038 [No Abstract] [Full Text] [Related]
2. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome? Sexton DJ. Circ Heart Fail; 2014 May; 7(3):536. PubMed ID: 24847129 [No Abstract] [Full Text] [Related]
3. Inhibition of the renin-angiotensin-aldosterone system: how to obtain this. Pende A, Montecucco F. Curr Pharm Des; 2012 May; 18(7):950-1. PubMed ID: 22283769 [No Abstract] [Full Text] [Related]
4. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection. Lambers Heerspink HJ. Contrib Nephrol; 2013 May; 179():7-14. PubMed ID: 23652444 [Abstract] [Full Text] [Related]
5. [Renoprotective treatments : renin-angiotensin-aldosterone system blockade and beyond]. Esnault V. Rev Prat; 2024 Jun; 74(6):s19-s22. PubMed ID: 39011717 [Abstract] [Full Text] [Related]
6. Renin-angiotensin-aldosterone system inhibitors in heart failure. Shearer F, Lang CC, Struthers AD. Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393 [Abstract] [Full Text] [Related]
7. Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease? Lattanzio MR, Weir MR. Curr Hypertens Rep; 2010 Oct; 12(5):369-77. PubMed ID: 20703958 [Abstract] [Full Text] [Related]
10. The renin-angiotensin-aldosterone system blockade in patients with advanced diabetic kidney disease. Bermejo S, García CO, Rodríguez E, Barrios C, Otero S, Mojal S, Pascual J, Soler MJ. Nefrologia (Engl Ed); 2018 Oct; 38(2):197-206. PubMed ID: 29102270 [Abstract] [Full Text] [Related]
11. Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases. Weinberger MH, Luft FC. Kidney Int; 2006 Dec; 70(12):2051-3. PubMed ID: 17136130 [Abstract] [Full Text] [Related]
12. Combined blockade of renin-angiotensin-aldosterone system reduced all-cause but not cardiovascular mortality in dialysis patients: A mediation analysis and systematic review. Li SM, He WB, Chen J, Cai QQ, Huang FF, Zhang K, Wang JF, Liu X, Huang H. Atherosclerosis; 2018 Feb; 269():35-41. PubMed ID: 29258005 [Abstract] [Full Text] [Related]
13. Aldosterone: The Missing Cardiorenal Link. Williams GH. Am J Nephrol; 2019 Feb; 50(5):329-332. PubMed ID: 31661688 [No Abstract] [Full Text] [Related]
14. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade. Shenoy SV, Nagaraju SP, Bhojaraja MV, Prabhu RA, Rangaswamy D, Rao IR. Nephrology (Carlton); 2021 Nov; 26(11):858-871. PubMed ID: 34176194 [Abstract] [Full Text] [Related]
15. Benefit of Renin Angiotensin Aldosterone Blockade in Kidney Transplant Recipients: Is the Verdict in or Still to Be Answered? Sawinski D, Mottl AK. Clin J Am Soc Nephrol; 2024 Jun 01; 19(6):691-693. PubMed ID: 38758607 [No Abstract] [Full Text] [Related]
16. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. Khatib R, Joseph P, Briel M, Yusuf S, Healey J. Int J Cardiol; 2013 Apr 30; 165(1):17-24. PubMed ID: 22421406 [Abstract] [Full Text] [Related]